SI21300A - Farmacevtske formulacije z alginati - Google Patents

Farmacevtske formulacije z alginati Download PDF

Info

Publication number
SI21300A
SI21300A SI200200242A SI200200242A SI21300A SI 21300 A SI21300 A SI 21300A SI 200200242 A SI200200242 A SI 200200242A SI 200200242 A SI200200242 A SI 200200242A SI 21300 A SI21300 A SI 21300A
Authority
SI
Slovenia
Prior art keywords
sodium
alginate
weight
pharmaceutical formulation
formulation according
Prior art date
Application number
SI200200242A
Other languages
English (en)
Slovenian (sl)
Inventor
Robert Pišek
Andrejka Kramar
Franc Vrečer
Maja Kincl
Marjanca Breznik
Original Assignee
Krka, Tovarna Zdravil, D.D., Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka, Tovarna Zdravil, D.D., Novo Mesto filed Critical Krka, Tovarna Zdravil, D.D., Novo Mesto
Priority to SI200200242A priority Critical patent/SI21300A/sl
Priority to UAA200504316A priority patent/UA80990C2/uk
Priority to EP03755718.8A priority patent/EP1560568B1/en
Priority to YU20050276A priority patent/RS52818B/sr
Priority to PCT/SI2003/000034 priority patent/WO2004032904A1/en
Priority to PL374487A priority patent/PL208591B1/pl
Priority to SI200332359T priority patent/SI1560568T1/sl
Priority to EA200500613A priority patent/EA007488B1/ru
Priority to AU2003273212A priority patent/AU2003273212A1/en
Publication of SI21300A publication Critical patent/SI21300A/sl
Priority to HRP20050312AA priority patent/HRP20050312B1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200200242A 2002-10-08 2002-10-08 Farmacevtske formulacije z alginati SI21300A (sl)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SI200200242A SI21300A (sl) 2002-10-08 2002-10-08 Farmacevtske formulacije z alginati
UAA200504316A UA80990C2 (en) 2002-10-08 2003-06-10 Controlled release pharmaceutical composition containing sodium alginate and sodium calcium alginate
EP03755718.8A EP1560568B1 (en) 2002-10-08 2003-10-06 Controlled release pharmaceutical compositions containing sodium alginate and sodium calcium alginate
YU20050276A RS52818B (sr) 2002-10-08 2003-10-06 Farmaceutska formulacija sa kontrolisanim otpuštanjem koja sadrži natrijum alginat i natrijum kalcijum alginat
PCT/SI2003/000034 WO2004032904A1 (en) 2002-10-08 2003-10-06 Controlled release pharmaceutical compositions containing sodium alginate and sodium calcium alginate
PL374487A PL208591B1 (pl) 2002-10-08 2003-10-06 Kompozycje farmaceutyczne o kontrolowanym uwalnianiu zawierające alginian sodowy i alginian sodowo-wapniowy
SI200332359T SI1560568T1 (sl) 2002-10-08 2003-10-06 Farmacevtski sestavki z nadzorovanim sproščanjem, ki vsebujejo natrijev alginat in natrijev-kalcijev alginat
EA200500613A EA007488B1 (ru) 2002-10-08 2003-10-06 Фармацевтические композиции с контролируемым высвобождением, содержащие альгинат натрия и альгинат натрия-кальция
AU2003273212A AU2003273212A1 (en) 2002-10-08 2003-10-06 Controlled release pharmaceutical compositions containing sodium alginate and sodium calcium alginate
HRP20050312AA HRP20050312B1 (hr) 2002-10-08 2005-04-06 Farmaceutski pripravci s kontroliranim oslobađanjem koji sadržavaju natrijev alginat i natrij kalcij alginat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200200242A SI21300A (sl) 2002-10-08 2002-10-08 Farmacevtske formulacije z alginati

Publications (1)

Publication Number Publication Date
SI21300A true SI21300A (sl) 2004-04-30

Family

ID=32091983

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200200242A SI21300A (sl) 2002-10-08 2002-10-08 Farmacevtske formulacije z alginati
SI200332359T SI1560568T1 (sl) 2002-10-08 2003-10-06 Farmacevtski sestavki z nadzorovanim sproščanjem, ki vsebujejo natrijev alginat in natrijev-kalcijev alginat

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200332359T SI1560568T1 (sl) 2002-10-08 2003-10-06 Farmacevtski sestavki z nadzorovanim sproščanjem, ki vsebujejo natrijev alginat in natrijev-kalcijev alginat

Country Status (9)

Country Link
EP (1) EP1560568B1 (sr)
AU (1) AU2003273212A1 (sr)
EA (1) EA007488B1 (sr)
HR (1) HRP20050312B1 (sr)
PL (1) PL208591B1 (sr)
RS (1) RS52818B (sr)
SI (2) SI21300A (sr)
UA (1) UA80990C2 (sr)
WO (1) WO2004032904A1 (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR122018068450B8 (pt) 2004-10-12 2021-07-27 Fmc Biopolymer As dispositivo implantável compreendendo gel de alginato
BRPI0815977A2 (pt) 2007-08-28 2017-06-13 Fmc Corp dispersão, kit e composição para fabricar a mesma, métodos para dispensar uma dispersão de alginato auto-geleificante retardada, para preparar um gel de alginato e para preparar alginato insolúvel/ partículas de íon geleificante, e, alginato ultrapuro insolúvel/partículas de íon geleificante.
CN108853039B (zh) * 2018-08-07 2021-03-09 河北君临药业有限公司 一种克拉霉素分散片及其生产工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583799D1 (de) * 1985-01-11 1991-09-19 Abbott Lab Ltd Feste zubereitung mit langsamer freisetzung.
EP0275336A1 (de) * 1987-01-20 1988-07-27 Knoll Ag Arzneimittelzubereitung mit protahierender Wirkung
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
SK282427B6 (sk) * 1997-06-11 2002-01-07 Abbott Laboratories Pevná farmaceutická kompozícia s riadeným uvoľňovaním

Also Published As

Publication number Publication date
EA200500613A1 (ru) 2005-10-27
EP1560568B1 (en) 2014-03-26
EA007488B1 (ru) 2006-10-27
SI1560568T1 (sl) 2014-08-29
RS20050276A (en) 2007-06-04
UA80990C2 (en) 2007-11-26
HRP20050312A2 (en) 2006-02-28
EP1560568A1 (en) 2005-08-10
PL374487A1 (en) 2005-10-31
AU2003273212A1 (en) 2004-05-04
WO2004032904A1 (en) 2004-04-22
HRP20050312B1 (hr) 2014-09-26
PL208591B1 (pl) 2011-05-31
RS52818B (sr) 2013-10-31

Similar Documents

Publication Publication Date Title
AU2006271314B2 (en) Gastroretentive formulations and manufacturing process thereof
US20110218216A1 (en) Extended release pharmaceutical composition of donepezil
CS270560B2 (en) Method of biologically active compounds solubilization
BRPI0608853B1 (pt) composições farmacêuticas e processo para a fabricação de microgrânulos de rifaximina gastrorresistentes
JP5420590B2 (ja) ｐＨ非依存延長放出性医薬組成物
IE862468L (en) Slow-release pharmaceutical agent
JP2010519201A (ja) シロスタゾールを含む制御放出製剤及びその製造方法
EA013426B1 (ru) Фармацевтические композиции, содержащие лерканидипин
JP2007063263A (ja) アムロジピン含有粒子およびそれからなる口腔内崩壊錠
EA033983B1 (ru) Фармацевтический комбинированный состав капсулы, содержащий тадалафил и тамсулозин
PL196665B1 (pl) Preparat o kontrolowanym uwalnianiu zawierający klarytromycynę i sposób jego wytwarzania
JP2005533774A (ja) ジバルプロエクスソジウムの放出遅延剤
TW201427720A (zh) 含有鈣拮抗劑及血管張力素ｉｉ受體拮抗劑之醫藥製劑之製造方法
HU221590B (hu) Béta-fenil-propiofenon-származékokat tartalmazó retard mikrotabletták
US20230012071A1 (en) Modified release pharmaceutical compositions of riociguat
JP2023071921A (ja) 様々な用量のレナリドミドの経口用錠剤組成物
US20100272794A1 (en) Pharmaceutical composition of memantine
SI21300A (sl) Farmacevtske formulacije z alginati
US20040146556A1 (en) Oral extended release tablets and methods of making and using the same
US20220273619A1 (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolylglycyl-l-tyrosinate and methods for preparing the same
JP2005528388A (ja) 改善された制御放出調製物
EP2461801A2 (en) Controlled release pharmaceutical compositions of milnacipran
WO2009087675A2 (en) Novel coated extended release pharmaceutical compositions of levetiracetam
JP2015514799A (ja) サルサレートの遅延放出性医薬組成物
EP3761965A1 (en) Ticagrelor-containing tablet formulation

Legal Events

Date Code Title Description
IF Valid on the prs date
KO00 Lapse of patent

Effective date: 20121019